Healthcare services

FNArena Windows (Sectors)

Introduction to FNArena Windows

FNArena Windows offers subscribers the option to investigate ASX-listed stocks against their peers. FNArena developed its own sector methodology which in our view overcomes many flaws and disadvantages connected with GICS sectors. Our system starts with three broad sector labels: COMMODITIES, FINANCIAL SERVICES and INDUSTRIALS. From here onwards subscribers can explore further through gradually narrowing branches. This is not investment advice, but simply another window on the Australian Stock Exchange to provide better insight and to assist FNArena subscribers while conducting their own market analysis.

Latest Stories

Tim Boreham highlights opportunities for SaaS company Alcidion, which tracks patients through the medical system

Dec 13 2022

Following first quarter results, some brokers anticipate rising margins for Ramsay Health Care though overseas operations are harder to forecast

Nov 15 2022


ASX CODE COMPANY NAME LAST PRICE 52WK HIGH 52WK LOW P/E CONSENSUS TARGET
ACL $3.01 $5.88 $2.87

$3.80

CAJ CAPITOL HEALTH LIMITED $0.31 $0.38 $0.27 19.4

$0.42

EBO EBOS GROUP LIMITED $41.32 $45.77 $31.10 35.5

$40.75

HLS HEALIUS LIMITED $3.19 $4.68 $2.78 24.7

$3.545

M7T MACH7 TECHNOLOGIES LIMITED $0.74 $0.85 $0.45

$1.34

MPL MEDIBANK PRIVATE LIMITED $2.91 $xx.xx $xx.xx xx.x xx.xx
MVF MONASH IVF GROUP LIMITED $1.08 $xx.xx $xx.xx xx.x xx.xx
NHF NIB HOLDINGS LIMITED $7.94 $xx.xx $xx.xx xx.x xx.xx
PSQ PACIFIC SMILES GROUP LIMITED $1.46 $xx.xx $xx.xx xx.x xx.xx
RHC RAMSAY HEALTH CARE LIMITED $66.69 $xx.xx $xx.xx xx.x xx.xx
SHL SONIC HEALTHCARE LIMITED $31.53 $xx.xx $xx.xx xx.x xx.xx
Previous Stories
Dr Boreham’s Crucible: Mach7 Technologies

Nov 14 2022

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player


Negative Industry Trends Impact Australian Clinical Labs

Aug 12 2022

FY22 results for Australian Clinical Labs missed expectations and brokers await an uptick in non-covid testing


Healius Offers Digital Carrot, Base Remains Soft

May 25 2022

Recovery in the core business remains important in the near-term for Healius, as benefits from covid testing look likely to soften in the remainder of the year, but longer-term digitisation remains a focus for the company


Ramsay Stakes Future on Mental Health

Dec 20 2021

Its latest acquisition has increased Ramsay Health Care’s exposure to the high growth mental health care segment, but potential opportunity has largely failed to impress analysts


Ramsay Health Care: Finally A Break-Out

Nov 09 2021

Michael Gable of Fairmont Equities notes Ramsay Health Care had been range-bound for a year thus a break-out is significant


Funding Overhang Weighs On Ramsay’s Rebound

Jun 10 2021

With earnings momentum coming out of covid, Ramsay Health Care looks set to rebound from the pandemic downturn in surgeries, but the Spire acquisition raises questions over its balance sheet and funding options


Treasure Chest: More Pfizer Growth For Ebos Group

May 24 2021

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Pfizer will now distribute its PBS medicines via a wholesale model and Ebos Group is one wholesaler/distributor that will benefit


Treasure Chest: Demand Pumps Ramsay Health

Mar 03 2021

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Long-term fundamentals are intact for Ramsay Health Care but views differ on the short-term trajectory as the pandemic still dominates


Healius Enjoying Testing Times

Dec 11 2020

Having divested of its medical centres, Healius has initiated a buyback, revised its dividend policy and outlined new profitability targets


The First Connection

Dec 10 2020

Tim Boreham discusses the future prospects of the health booking platform – 1st Group – with some new opportunities on the horizon